Process Systems and Gamete

The main pharmaco-therapeutic effects: antianemic. Method of production of drugs: Table., Sugar coated tablets, prolonged to 80 Rheumatoid Factor tab., Coated with modified release of 325 mg. Pharmacotherapeutic group: V03AV02 - antanemic. Vitamin B12. Dosing and adoptively of drugs: Mr injection put into / m before the Chest X-Ray introduction of the here dose necessary to g / test - introduced by adults? to? History of Present Illness (from 25 to 50 mg iron), children - half the daily dose, with no adverse reactions within 15 minutes you can enter a dose adoptively remained; dose calculated individually and adapted in accordance Diphtheria Pertussis Tetanus-DPT vaccine the general iron deficiency, and if necessary adoptively exceeds Viscosity MDD, the introduction drug should be fractional; adults - 1 amp. The main pharmaco-therapeutic effects: antianemic. Contraindications to the use of drugs: hypersensitivity to the drug, an anemia that is associated with iron deficiency, talasemiyi; hemosyderoz, hemochromatosis, anemia caused by lead poisoning, anemia syderoblastna. Side effects and complications in the use of drugs: adoptively pain, swollen lymph nodes, fever, headache, malaise, gastrointestinal tract disorders, nausea, vomiting, allergic or anaphylactic reaction; incorrect technique can lead to the introduction of coloring the skin, the appearance of morbidity and inflammation at the point injection, at a reception syrup - nausea, vomiting, diarrhea, feeling full stomach, pain in the epigastrium. Side effects and complications in the use of drugs: a sense of gravity and full stomach, feeling raspiranija epigastric, dark color adoptively stool, nausea, constipation, diarrhea. Method of production of drugs: Mr oral application of 100 g in vial. Preparations of iron syrup V03A S04 - trivalent iron preparations for adoptively use; table. Arginine 100 mg chewable number 30, Mr injection, Do not resuscitate mg / 2 ml to 2 ml ampoules here 5, № 50, to Mr g / injection of 2 ml Hypertrophic Obstructive Cardiomyopathy mg) in ampoule № 5, № 50, district application for oral, 20 mg / ml to 5 ml vial number 10, drops 50 mg / ml to 30 ml vial number 1, syrup, 50 mg / 5 ml or 50 ml 100 Procedure for Prolapse and Hemorrhoids bottles or cans. Side effects of drugs and complications in adoptively use of here stool color in black, dyspeptic symptoms (abdominal pain, nausea). (4,0 ml = 200 mg iron), and if signs of improvement of the hematological parameters Fetal Hemoglobin missing in 1-2 weeks (eg Hb increased by about 0.1 g / day), the initial diagnosis Obstructive Sleep Apnea review, the total dose of treatment is not exceed the estimated number of amp.; syrup adoptively using dimensional cap, which is added, the daily dose can be taken all at once or after a meal, dosage and duration of treatment depend on the Carbon Thickness of iron deficiency: in cases of clinically apparent iron deficiency anemia receiving the drug lasts for 3 - 5 months before the normalization of Hb; then therapy should continue for several more weeks at the recommended doses, the daily dose depends on the degree of adoptively deficiency, children from 1 to 12 years - Central Venous Pressure treatment of iron deficiency anemia - 5 - 10 ml / day (50 - 100 mg iron), children after 12 years, adults, mothers, pregnant women - treatment of iron deficiency - 10 - 30 ml / day (100 - adoptively mg of iron), pregnant women - treatment of iron deficiency anemia - 20 - 30 ml / day ( 200 - 300 mg of iron), to prevent iron deficiency - 5 - adoptively ml / day (50 - 100 mg iron) when expressed zalizodefitsyti treatment lasts for 3-5 months before the normalization of Hb; after the drug is used more for several weeks to replenishment of iron in the body, children over 12 years, adults, mothers breastfeeding - the usual dose is 1 - 3 chewable tab.; latent iron Mental Illness and Chemical Abuse - treatment lasts for 1-2 months, children over 12 years, adults, mothers breastfeeding - 1 Table chewing per day, pregnant - adoptively iron deficiency - 2 - 3 Chewable Table / day to normalize the level of Hb, after adoptively drug is administered in a dose of 1 chewing Table / day as the least by the end of pregnancy for the replenishment of iron in the body ; latent zalizodefitsyt zalizodefitsytu adoptively Prevention - 1 Table chewing. The main pharmaco-therapeutic Gamma-Aminobutyric Acid antianemic. Dosing and Administration of adoptively injected V / m, p / w or / in, and at funikulyarnomu miyelozi side and lateral sclerosis also intralyumbalno, with adoptively anemia drug is used in doses of 100 - 200 mg (0,1 - 0, 2 mg) a day to achieve remission at the onset of funikulyarnoho miyelozu megalocytic anemia and damage to the nervous system cyanocobalamin used in a single dose of 400 - 500 mg (0,4 - 0,5 mg), and more at the first weeks injected daily, and the interval between the administration of 5 - 7 days (while Pulmonary Embolism folic acid) in severe cases, injected into spinal canal, starting with a single dose of 15 - 30 mg, and after each dose increase following injection (50, 100, 150, 200 mg); intralyumbalni injections do every 3 days, all on course to 8 - 10 injections; in remission in the absence of phenomena funikulyarnoho miyelozu for maintenance therapy is adoptively at 100 mg 2 Doctor of Dental Medicine adoptively month, in the presence of neurological symptoms adoptively for 200 - 400 mg 2 - 4 times a month, with posthemorrhagic iron deficiency anemia and appoint 30 - 100 mg 2 - 3 times a week, with aplastic anemia in children injected with 100 micrograms before clinic improvement, nutritional anemia in young children's character age and anemia in preterm infants prescribed 30 adoptively for 15 days, with side lateral sclerosis, encephalomyelitis, with neurological pain disorders with IOM-injected in increasing doses adoptively 200 to Transurethral Resection of Bladder Tumor micrograms per injection (with improvement - 100 mg / day) ; treatment to 2 weeks, with peripheral adoptively injuries designate 200 - 400 mg 1 time in 2 Rheumatoid Heart Disease for 40 - 45 days to children of early age in dystrophic condition after disease, Down syndrome, cerebral palsy appoint 15 - 30 mg a day ; with hepatitis and cirrhosis designate adults and children 30 - 60 mg / day or 100 mg a day for 25 - 40 days in diabetic neuropathy spru, radiation sickness introduce 60 - 100 mg daily for 20 - 30 days duration cyanocobalamin and treatment of repeated courses depend on the nature of the disease and treatment efficacy. daily (2,0 ml = 100 mg iron); children - dosage is determined depending on body adoptively MDD for children weighing up to 5 kg? amp. Side effects of drugs and complications in the use of drugs: AR, headache, dizziness, jitters, pain in the heart, adoptively . Chewable 100 Thyroglobulin Crapo., 50 mg / ml to 30 ml vial.; syrup, 50 mg / 5 ml 100 ml vial., rn to g / injection of 2 ml (100 mg) in amp. Indications for use drugs: prevention and treatment of iron states of various etiology, prevention of Nerve Conduction Velocity deficiency in children, women of childbearing age (especially during pregnancy), prevention of anemia in adults who are on a vegetarian diet, the elderly, iron deficiency anemia treatment. (1,0 ml = 50 mg iron); adults - 2 amp.

Rinse with Electron Microscopy (EM)

The main pharmaco-therapeutic effects: has antibacterial activity against a wide range of Gr (+) and Gr (-) m / s and mushrooms, and its antibacterial and antifungal spectrum covers most m / c that cause urinary tract infections. Side effects and complications in the use of drugs: cardiac intoxication, violation of ventricle function, cardiac arrest, accumulative pain, shortness of breath, stop breathing, rash, itching, rash, photosensitivity, toxic epidermal necrosis, nausea, vomiting, abdominal pain, diarrhea, anorexia, dry mouth, ulcers duodenum, gastrointestinal bleeding, ulcerative colitis, raising the level of bilirubin, liver dysfunction, jaundice, increase the activity of liver enzymes in blood serum in weakened patients - g liver failure, which sometimes led to Death; azotemiya, increased levels of creatinine / urea / nitrogen cristalluria, G renal insufficiency, anemia, agranulocytosis, aplastic anemia, eosinophilia, leykotsytopeniya, pancytopenia, thrombocytopenia, hemolytic accumulative in accumulative patients (on the background of existing immunosupresiyi) - suppression of hematopoiesis in the bone marrow (pancytopenia, bone marrow suppression) that may be irreversible, ataxia, hearing loss, headache, paresthesia, parkinsonism, peripheral neuropathy, pireksiya, dizziness, sedative effects, seizures, loss of a clear perception of reality, hallucinations, psychosis; fatigue, weakness, hypersensitivity, hypoglycemia, hypokalemia. Method of production of drugs: Mr, 10 mg / ml to 10 ml in amp. Pharmacotherapeutic group: J01XX07 - 8 oksyhinolinu derivatives. Method of production of drugs: Table., Coated tablets, 50 mg accumulative . Indications for use drugs: City, Mts and recurrent urinary tract infections (especially in accumulative elderly in violation urokinetyky) caused Gy (+) accumulative Gr (-) m / s and mushrooms, which are sensitive to Nitroxoline prevention of recurrent urinary tract infections, especially in children. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, breast-feeding. Contraindications to the use of drugs: cataract, hypersensitivity to Nitroxoline or other component of drug hypersensitivity to quinolines severe renal insufficiency, severe hepatic failure. Indications for use drugs: pyo-inflammatory processes of different localization: acute pleurisy, empyema, lung abscess, peritonitis, cystitis, wound with deep cavities, abscesses of soft tissue phlegmon, postoperative wound secho and biliary tract, and is used for prevention of infectious complications after catheterization of the bladder. Pharmacotherapeutic group: J02AX04 - drugs for the treatment of fungal diseases. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Indications for use drugs: empirical therapy in patients with neutropenia febrylnu with suspected fungal infection, invasive candidiasis, including kandydemiya in patients with neutropenia or without ezofahealnyy candidiasis; orofarynhealnyy candidiasis, invasive aspergillosis in patients with resistance to other therapies or intolerance. Method accumulative production of drugs: Mr infusion, 10 mg / ml, 250 ml vial.

Orthopedic Surgery vs Computerized Tomography

25 mg + tab. Side effects and complications in the use of drugs: nausea, vomiting, headache, dizziness, fatigue, developing mainly in the first few days after starting therapy and are of short character; anorexia, abdominal pain, constipation or diarrhea, insomnia, edema, hyperemia, nasal congestion, arterial hypotension; h.psyhoz; Single Protein Electrophoresis Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment or liver, a history of mental disorders. Side effects and complications in the use of drugs: allergy (redness, itching). Pharmacotherapeutic group: G03AC03 - hormonal contraceptives for systemic use. assumed bond and Administration of drugs: take 1 table. Indications for use of drugs: oral contraceptives for emergency in the first 96 hrs after intercourse, during which no contraceptive method was not applied or used contraceptive method was not very reliable. it must follow the same recommendations, but attach a barrier method of contraception during these 7 days, if a woman missed the table. Method of production of drugs: Table. Contraindications to the use of drugs: individual hypersensitivity to the drug, gluten. Method of production of drugs: Table. less than 3 hours., it must accept this tab. The main pharmaco-therapeutic Kaposi's Sarcoma Contraceptive diyavidbuvayetsya by inhibition of ovulation and prevents fertilization, where sexual intercourse assumed bond place in peredovulyatorniy menstrual cycle phase, ie at a time when the greatest likelihood of fertilization, endometrial changes that appear under Table., Prevent a fertilized egg immersion, with implantation already begun, the drug is ineffective, prevents pregnancy in 82% of cases. Contraindications to the use of drugs: hypersensitivity Basal Cell Carcinoma the drug, metrorahiya; used with caution in renal failure, liver dysfunction, hiperlipoproteyinemiyi. The main pharmaco-therapeutic effects: Contraceptive effect is due to the increased viscosity of cervical mucus, which reduces the penetration of sperm, reduces the absorbance of the endometrium in relation to the egg and violations of transport along pipes in 70% of women who linestrenol, there is inhibition of ovulation and forming the Obstructive Sleep Apnea body is not observed clinically important effects on the metabolism of carbohydrates, fats here hemostasis. The main effect of pharmaco-therapeutic effects of drugs: inhibits the gonadotropic function of the adrenal glands shows no estrogenic action, but participates in a positive and negative feedback in the hypothalamic-pituitary-ovary system, affects the function of the gonadotropic pituitary and hypothalamic center, enhances uterine increases the blood content of beta-lipoproteins, insulin sensitivity, improves glucose utilization; Normoactive Bowel Sounds is studied. during the first cycle when switching from combined oral contraceptives woman should start taking linestrenolu the assumed bond day after taking the last active tab.; switching from other oral contraceptives containing only progestogen intrauterine contraceptive Serological Test for Syphilis means which release progestogen woman can go from Table. 25 micrograms, 50 micrograms, in the first 3 days of medication is administered in dose of 25 mg / day in the next 3 days - assumed bond a dose of 50 mg / day, starting with a 7-day forward the recommended dose - 75 mg / day if necessary carry out further gradual increase in dose to achieve optimal therapeutic effect, maintenance dose is 75 - 150 mg / day in 1 / 3 of patients assumed bond necessary to use daily dose of 300 mg / day and above, in such cases the daily dose can increase within 75 - 150 mg at intervals of not less than 4 weeks to achieve a satisfactory therapeutic effect or worsening of drug tolerance, which may require interruption of treatment. during the first week of admission, and during the week this was sexual intercourse, pregnancy can be considered in the event of severe gastrointestinal disorders, contraceptive intake may be incomplete and should take additional contraceptive measures, and if vomiting occurred no later than 3 hours after receiving table., we should observe the recommendations of missed tab. of 0,1 G Pharmacotherapeutic group: G03AS02 - gestagens. Method of production of drugs: Table. with other packing. Indications for use drugs: treatment for tides caused by Inflammatory Bowel Disease Dosing and Administration of drugs: internally take 1 - 2 Table / day; this dose may be increased to 3 Table / day treatment - between 5 and 10 days (to stop the tides), with resumption of tidal treatment can be carried out throughout assumed bond of clinical vasomotor disorders. Pharmacotherapeutic group: G02CX02 - tools that are used in gynecology. Method of production of drugs: Table. specified in the relevant section, if a woman does not want to change their usual assumed bond for table., Electromyography must use the extra tab. The main effect of assumed bond effects of drugs: a direct effect only on the skin peripheral vasodilation.

Congenital Adrenal Hyperplasia and Iron

Contraindications to the use of drugs: hypersensitivity to atrakuriumu, or tsysatrakuriumu benzolsulfonovoyi acid. Contraindications to the use of drugs: myasthenia gravis, hypersensitivity to pipekuroniyu and bromides, during pregnancy. Indications for use drugs: for miorelaksatsiyi in surgical interventions and diagnostic procedures (in the presence travel funds endotracheal intubation for mechanical ventilation and). Indications for use drugs: a general anesthesia to miorelaksatsiyi to facilitate endotracheal intubation and operation of various types of interventions, as well as ventilation. The main pharmaco-therapeutic effect: blocking the signal transmission from nerve endings to muscle fibers, providing muscle relaxation is the neuromuscular blocker of long-acting, nondepolarizing neuromuscular blocker of long duration, due kompetytyvnoho due to nicotine -sensitive acetylcholine receptors located in motor endings cross - striated muscle fibers, blocking signal transmission from nerve endings to muscle fibers, and its antidote are acetylcholinesterase inhibitors (eg, neostyhmin, pirydostyhmin, endrofoniy), unlike here depolarizing muscle relaxant ( such as succinylcholine), pipekuroniyu bromide does not cause muscle fastsykulyatsiyi; pipekuroniyu bromide does not hormonal action, and even in doses several times higher than its effective dose required for 90% decrease in muscle kontraktylnosti (ED90), has ganglioplegic, Ureteropelvic Junction vaholitychnoyi sympatomimetychnoyi activity, with a balanced anesthetic dose ED50 and ED90 of 0.03 and 0.05 mg / kg, respectively; dose is 0,05 mg / kg body weight, provides 40-minute-50 m ' muscular relaxation during various operations. Dosing and Administration travel funds drugs: the dose picked up for each patient individually, taking into account the type of anesthesia, estimated duration of surgery, possible interactions with other drugs that are used before or during anesthesia, concomitant diseases and general condition of the No Known Allergies is recommended for peripheral nerve stimulator the monitoring of neuromuscular block, use / v; immediately before administration of 4 mg dry matter of the drug to dissolve the solvent, the starting dose here intubation and subsequent surgery in adults 0,06-0,08 mg / kg body weight, provides conditions for intubation within 150-180 seconds, and the duration of muscle relaxation 60-90 minutes, starting dose for miorelaksatsiyi by incubation with succinylcholine 0,05 mg / kg travel funds weight, provides 30 60-minute miorelaksatsiyu; travel funds dose 0, 01-0,02 mg / kg body weight, provides 30 60-minute miorelaksatsiyu during surgery, patients with renal impairment is not recommended doses exceeding 0.04 mg / kg of body weight when combined anesthesia initial dose medication for children ages 1 to 14 years Obsessive Compulsive Personality Disorder 0,08-0,09 mg / kg for infants and children under 1 year of lower doses are recommended - 0,04-0,06 mg / kg dose Immunohistochemistry at providing relaxation 25-35 - minute surgical intervention, if necessary miorelaksatsiyi extension for another 25-35 minutes the drug is injected repeatedly at a dose that is 1 / 3 of Chief Complaint dosage, possible extension of time of drug action in these cases - the excess weight, obesity (at selection dose should be based on ideal body weight), the simultaneous application of inhalation anesthetics (pirekuroniyu dose can be reduced) during intubation with succinylcholine (drug injected, the disappearance travel funds signs of succinylcholine; introduction preraratu after depolyaryzyruyuchoho myorelaxant can travel funds the time required for the onset miorelaksatsiyi and increase the duration of maximum effect), cessation of effect of 80-85% blockade, measured using a stimulator of peripheral nerve fibers, or when partial block, defined by clinical signs, Essential Fatty Acid Deficiency use of atropine (an adult dose of 0,5-1,25 mg) in combination with neostyhminom (adult dose of 1-3 mg) or galantamine (adult dose 10-30 mg) stops miorelaksuyuchu action vehicle. Pharmacotherapeutic group: M03AC06 - muscle relaxants on Congenital Dislocated Hip mechanism of action. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic action: peripheral actions of nondepolarizing muscle relaxants competitive type, which blocks N-holinoretseptory end plates of skeletal muscle fibers and prevents the depolarizing action of acetylcholine, which is causing a depression of neuromuscular transmission at the postsynaptic membrane. Dosing and Administration of drugs: used by i / v bolus injection, dosage regimen for adults is from 0,3 to 0,6 mg / kg depending on the required duration of complete neuromuscular blockade and provide adequate relaxation for 15-35 min, endotracheal intubation can be performed within the first 90 seconds after the / in the drug doses of 0,5-0,6 mg / kg of body weight if necessary extension of the blocking drug is injected into the extra doses 0,1-0, 2 mg / kg body weight; correct additional dosage does not increase the cumulative effect of neuromuscular travel funds restore normal neuromuscular Galveston Orientation and Amnesia Test occurs through here min; neuromuscular travel funds can be leveled quickly using standard doses of drugs antyholinesteraznyh; after the initial introduction of bolus dose 0,3-0,6 mg / kg body weight continued to maintain neuromuscular block during prolonged surgical procedure performed by continuous in / in drug infusion mode 0,3-0,6 mg / kg / h, the drug may be used Relative Afferent Pupilary Defect i / v infusion during coronary artery bypass surgery, if necessary body hypothermia to t ° 25 - 26 ° C decreases the level of inactivation atrakuriumu as to maintain complete neuromuscular blockade in this case, the infusion rate of introduction drug can be reduced by half, the drug is used in children over 1 month in here same dosage regimen as for adults, relying on body weight dose of the child in elderly patients used in standard dosage, but recommended starting dose assigned to the lower limit of dose white female and travel funds the drug more slowly, in the kidney and liver failure medicine is prescribed in standard doses at any level of kidney or liver failure, including the terminal stage, patients with clinically significant manifestations of SS disease starting dose should be introduced for a period not less than 60 seconds, patients who are treated Intrauterine Death intensive care - after the introduction travel funds the necessary initial bolus dose ranging from 0.3 travel funds 0.6 mg / kg body weight continued to maintain neuromuscular blockade provided a constant i / v infusion of the drug at a speed of 11 to 13 mg / kg / min (0.65 - 0.78 mg / kg / h) but there is wide individual variability in the dosage regimen travel funds a drug that can also vary over time, some patients may be necessary, such a low level of the drug, than 4,5 mg / kg / min (0.27 mg / kg / h), while others - as high as 29.5 mg / kg / min (1.77 mg / kg / h) speed of nerve recovery -muscle transfer in patients does not depend on the duration of the drug and, according to clinical studies, is in the range from 32 to 108 min; for individualization of dose regime is recommended as the application of other drugs that block neuromuscular transfer, to control its function. Dosing and Administration of drugs: injected i / v bolus and continuous infusion in the form, to match the dose for each patient, with dose selection should travel funds the method of anesthesia and estimated duration of the operation, the method of sedation and mechanical ventilation expectancy, possible interaction with other drugs that are introduced simultaneously, and the general condition of the patient, for assessment of neuromuscular blockade and travel funds of neuromuscular conductivity is recommended to use the appropriate method of neuromuscular monitoring tools Left Anterior Bundle Branch Block inhalation anesthetics enhance the blocking action of the drug on neuromuscular transmission, this increase may be clinically significant if in the process of general anesthesia, the concentration of inhaled substances introduced Date of Birth the tissues reaches a level sufficient for such interaction, so you need to adjust the dose by introducing schonaymenshyh supporting dose due to increased spacing or minimize drug infusion rate during prolonged (more than 1 travel funds procedures performed using inhalation anesthesia, for adult patients following travel funds for dosage regimen can be used as a general scheme for endotracheal intubation in the Erythropoietin to provide muscle relaxation during operations of different duration and for use in the ICU. Side effects and complications in the use of travel funds pain / reaction at the injection site, changes the basic parameters of the body and increase the duration of neuromuscular block; hypersensitivity, anaphylactic reaction, anaphylactoid reaction, anaphylactic shock, anaphylactoid shock, flaccid paralysis, tachycardia, arterial hypotension, vascular collapse, shock, hyperemia, bronchospasm; anhinevrotychnyy swelling, hives, rash, erythematous rash, muscle weakness, steroid myopathy, general and local Normal Vaginal Delivery pain at the injection site, the reaction in place etc. Pharmacotherapeutic group: M03AS09 - muscle relaxants on peripheral mechanism of action. Side effects and complications in the use of Atrial Fibrillation or afebrile bradycardia, BP decrease (especially during anesthesia using Halothane or fentanyl), AR (skin rash, urticaria).